Drug Price Transparency
Drug Price Transparency organizes records from CMS data API into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
| Record | Record Date | Vuga Group | Change Status | Recency Days | Public Significance Score |
|---|---|---|---|---|---|
| Abilify Asimtufii | 01/01/2024 | Aripiprazole | increased | 972.23 | 100 |
| Abilify Asimtufii | 01/01/2024 | Aripiprazole | increased | 972.23 | 100 |
| Abilify Maintena | 01/01/2024 | Aripiprazole | increased | 972.23 | 100 |
| Abilify Maintena | 01/01/2024 | Aripiprazole | increased | 972.23 | 100 |
| Abraxane | 01/01/2024 | Paclitaxel Protein-Bound | increased | 972.23 | 100 |
| Abraxane | 01/01/2024 | Paclitaxel Protein-Bound | increased | 972.23 | 100 |
| Abrysvo | 01/01/2024 | Rsv Vacc, Pref A And Pref B/PF | increased | 972.23 | 100 |
| Abrysvo | 01/01/2024 | Rsv Vacc, Pref A And Pref B/PF | increased | 972.23 | 100 |
| Abrysvo | 01/01/2024 | Rsv Vacc, Pref A And Pref B/PF | increased | 972.23 | 100 |
| Actemra Actpen | 01/01/2024 | Tocilizumab | increased | 972.23 | 100 |
| Actemra Actpen | 01/01/2024 | Tocilizumab | increased | 972.23 | 100 |
| Actemra* | 01/01/2024 | Tocilizumab | increased | 972.23 | 100 |
| Actemra* | 01/01/2024 | Tocilizumab | increased | 972.23 | 100 |
| Acthar Selfject | 01/01/2024 | Corticotropin | increased | 972.23 | 100 |
| Acthar Selfject | 01/01/2024 | Corticotropin | increased | 972.23 | 100 |
| Acthar | 01/01/2024 | Corticotropin | increased | 972.23 | 100 |
| Acthar | 01/01/2024 | Corticotropin | increased | 972.23 | 100 |
| Actimmune | 01/01/2024 | Interferon Gamma-1b,Recomb. | increased | 972.23 | 100 |
| Actimmune | 01/01/2024 | Interferon Gamma-1b,Recomb. | increased | 972.23 | 100 |
| Actonel | 01/01/2024 | Risedronate Sodium | increased | 972.23 | 100 |
| Actonel | 01/01/2024 | Risedronate Sodium | increased | 972.23 | 100 |
| Adakveo | 01/01/2024 | Crizanlizumab-Tmca | increased | 972.23 | 100 |
| Adakveo | 01/01/2024 | Crizanlizumab-Tmca | increased | 972.23 | 100 |
| Adalimumab-Aacf(Cf) Pen (2 Pk) | 01/01/2024 | Adalimumab-Aacf | increased | 972.23 | 100 |
| Adalimumab-Aacf(Cf) Pen (2 Pk) | 01/01/2024 | Adalimumab-Aacf | increased | 972.23 | 100 |
| Adalimumab-Aaty(Cf) Autoinj(2) | 01/01/2024 | Adalimumab-Aaty | increased | 972.23 | 100 |
| Adalimumab-Aaty(Cf) Autoinj(2) | 01/01/2024 | Adalimumab-Aaty | increased | 972.23 | 100 |
| Adalimumab-Adaz(Cf) Pen | 01/01/2024 | Adalimumab-Adaz | increased | 972.23 | 100 |
| Adalimumab-Adaz(Cf) Pen | 01/01/2024 | Adalimumab-Adaz | increased | 972.23 | 100 |
| Adalimumab-Adaz(Cf) | 01/01/2024 | Adalimumab-Adaz | increased | 972.23 | 100 |
| Adalimumab-Adaz(Cf) | 01/01/2024 | Adalimumab-Adaz | increased | 972.23 | 100 |
| Adalimumab-Adbm(Cf) Pen | 01/01/2024 | Adalimumab-Adbm | increased | 972.23 | 100 |
| Adalimumab-Adbm(Cf) Pen | 01/01/2024 | Adalimumab-Adbm | increased | 972.23 | 100 |
| Adalimumab-Adbm(Cf)pen | 01/01/2024 | Adalimumab-Adbm | increased | 972.23 | 100 |
| Adalimumab-Adbm(Cf)pen | 01/01/2024 | Adalimumab-Adbm | increased | 972.23 | 100 |
| Adalimumab-Adbm(Cf) | 01/01/2024 | Adalimumab-Adbm | increased | 972.23 | 100 |
| Adalimumab-Adbm(Cf) | 01/01/2024 | Adalimumab-Adbm | increased | 972.23 | 100 |
| Adalimumab-Fkjp(Cf) Pen | 01/01/2024 | Adalimumab-Fkjp | increased | 972.23 | 100 |
| Adalimumab-Fkjp(Cf) Pen | 01/01/2024 | Adalimumab-Fkjp | increased | 972.23 | 100 |
| Adalimumab-Fkjp(Cf) Pen | 01/01/2024 | Adalimumab-Fkjp | increased | 972.23 | 100 |
| Adalimumab-Fkjp(Cf) | 01/01/2024 | Adalimumab-Fkjp | increased | 972.23 | 100 |
| Adalimumab-Fkjp(Cf) | 01/01/2024 | Adalimumab-Fkjp | increased | 972.23 | 100 |
| Adalimumab-Fkjp(Cf) | 01/01/2024 | Adalimumab-Fkjp | increased | 972.23 | 100 |
| Adalimumab-Ryvk(Cf) Autoinject | 01/01/2024 | Adalimumab-Ryvk | increased | 972.23 | 100 |
| Adalimumab-Ryvk(Cf) Autoinject | 01/01/2024 | Adalimumab-Ryvk | increased | 972.23 | 100 |
| Adbry Autoinjector | 01/01/2024 | Tralokinumab-Ldrm | increased | 972.23 | 100 |
| Adbry Autoinjector | 01/01/2024 | Tralokinumab-Ldrm | increased | 972.23 | 100 |
| Adbry | 01/01/2024 | Tralokinumab-Ldrm | increased | 972.23 | 100 |
| Adbry | 01/01/2024 | Tralokinumab-Ldrm | increased | 972.23 | 100 |
| Adcetris | 01/01/2024 | Brentuximab Vedotin | increased | 972.23 | 100 |